SC 70935
Latest Information Update: 23 Sep 2021
At a glance
- Originator Pharmacia Corporation
- Class
- Mechanism of Action Granulocyte colony-stimulating factor receptor agonists; Interleukin 3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neutropenia
Most Recent Events
- 05 Apr 2000 Monsanto has merged with Pharmacia & Upjohn to form Pharmacia Corporation
- 04 Aug 1998 Phase-III clinical trials for Neutropenia in USA (SC)